Inventor
JEFFREY MIHALIC
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
PatentTitleYear
12,582,722Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway202612,583,862Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway202611,866,442Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway202411,479,556Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to NURIX THERAPEUTICS INC (4)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NURIX THERAPEUTICS INC | 4 | 2022–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2022–2026 |